322 related articles for article (PubMed ID: 12456589)
1. Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors.
Sluyter R; Wiley JS
Int Immunol; 2002 Dec; 14(12):1415-21. PubMed ID: 12456589
[TBL] [Abstract][Full Text] [Related]
2. Human epidermal and monocyte-derived langerhans cells express functional P2X receptors.
Georgiou JG; Skarratt KK; Fuller SJ; Martin CJ; Christopherson RI; Wiley JS; Sluyter R
J Invest Dermatol; 2005 Sep; 125(3):482-90. PubMed ID: 16117789
[TBL] [Abstract][Full Text] [Related]
3. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.
Gu B; Bendall LJ; Wiley JS
Blood; 1998 Aug; 92(3):946-51. PubMed ID: 9680363
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells.
Farrell AW; Gadeock S; Pupovac A; Wang B; Jalilian I; Ranson M; Sluyter R
Biochim Biophys Acta; 2010 Nov; 1800(11):1173-82. PubMed ID: 20647033
[TBL] [Abstract][Full Text] [Related]
5. Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.
Pupovac A; Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2015 Jan; 93(1):77-85. PubMed ID: 25155463
[TBL] [Abstract][Full Text] [Related]
6. Human P2X7 receptor activation induces the rapid shedding of CXCL16.
Pupovac A; Foster CM; Sluyter R
Biochem Biophys Res Commun; 2013 Mar; 432(4):626-31. PubMed ID: 23428418
[TBL] [Abstract][Full Text] [Related]
7. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
Wiley JS; Gargett CE; Zhang W; Snook MB; Jamieson GP
Am J Physiol; 1998 Nov; 275(5):C1224-31. PubMed ID: 9814970
[TBL] [Abstract][Full Text] [Related]
8. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes.
Sluyter R; Shemon AN; Wiley JS
J Immunol; 2004 Mar; 172(6):3399-405. PubMed ID: 15004138
[TBL] [Abstract][Full Text] [Related]
9. ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors.
Sperlágh B; Haskó G; Németh Z; Vizi ES
Neurochem Int; 1998 Sep; 33(3):209-15. PubMed ID: 9759915
[TBL] [Abstract][Full Text] [Related]
10. Activation of the P2Z/P2X7 receptor in human lymphocytes produces a delayed permeability lesion: involvement of phospholipase D.
Fernando KC; Gargett CE; Wiley JS
Arch Biochem Biophys; 1999 Feb; 362(2):197-202. PubMed ID: 9989927
[TBL] [Abstract][Full Text] [Related]
11. ATP promotes the fast migration of dendritic cells through the activity of pannexin 1 channels and P2X
Sáez PJ; Vargas P; Shoji KF; Harcha PA; Lennon-Duménil AM; Sáez JC
Sci Signal; 2017 Nov; 10(506):. PubMed ID: 29162744
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors.
Schulze-Lohoff E; Hugo C; Rost S; Arnold S; Gruber A; Brüne B; Sterzel RB
Am J Physiol; 1998 Dec; 275(6):F962-71. PubMed ID: 9843914
[TBL] [Abstract][Full Text] [Related]
13. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues.
Humphreys BD; Virginio C; Surprenant A; Rice J; Dubyak GR
Mol Pharmacol; 1998 Jul; 54(1):22-32. PubMed ID: 9658186
[TBL] [Abstract][Full Text] [Related]
14. Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X7 receptor.
Sluyter R; Shemon AN; Barden JA; Wiley JS
J Biol Chem; 2004 Oct; 279(43):44749-55. PubMed ID: 15304508
[TBL] [Abstract][Full Text] [Related]
15. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes.
Gargett CE; Wiley JS
Br J Pharmacol; 1997 Apr; 120(8):1483-90. PubMed ID: 9113369
[TBL] [Abstract][Full Text] [Related]
16. Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinocepters.
Jamieson GP; Snook MB; Thurlow PJ; Wiley JS
J Cell Physiol; 1996 Mar; 166(3):637-42. PubMed ID: 8600168
[TBL] [Abstract][Full Text] [Related]
17. 6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist.
Cuthbertson P; Elhage A; Al-Rifai D; Sophocleous RA; Turner RJ; Aboelela A; Majed H; Bujaroski RS; Jalilian I; Kelso MJ; Watson D; Buckley BJ; Sluyter R
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139148
[TBL] [Abstract][Full Text] [Related]
18. P2X7 receptor polymorphism impairs extracellular adenosine 5'-triphosphate-induced interleukin-18 release from human monocytes.
Sluyter R; Dalitz JG; Wiley JS
Genes Immun; 2004 Nov; 5(7):588-91. PubMed ID: 15306849
[TBL] [Abstract][Full Text] [Related]
19. Expression of a P2X7 receptor by a subpopulation of human osteoblasts.
Gartland A; Hipskind RA; Gallagher JA; Bowler WB
J Bone Miner Res; 2001 May; 16(5):846-56. PubMed ID: 11341329
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line.
Takenouchi T; Ogihara K; Sato M; Kitani H
Biochim Biophys Acta; 2005 Nov; 1726(2):177-86. PubMed ID: 16122875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
